Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Reexamination Certificate
2004-10-08
2009-10-27
Davis, Zinna N (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
C514S557000, C546S290000, C562S465000
Reexamination Certificate
active
07608639
ABSTRACT:
The present invention is directed to a compound of formula (I), or a pharmaceutically acceptable salt, solvate, hydrate or stereoisomer thereof, which is useful in treating or preventing disorders mediated by a peroxisome proliferator activated receptor (PPAR), such as syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis, and other disorders related to syndrome X and cardiovascular diseases.
REFERENCES:
patent: 0 307 103 (1988-08-01), None
patent: 0 307 103 (1988-08-01), None
patent: 0 597 102 (1992-07-01), None
patent: 0 696 585 (1994-04-01), None
patent: 0 647 612 (1994-09-01), None
patent: 1563871 (1980-04-01), None
patent: 08 059 638 (1996-03-01), None
patent: WO 2004/093799 (2004-11-01), None
Crews, A.D. et al, “Synthesis and Herbalicidal Activity of bis-Aryloxybenzenes: A New Structural Class of Protox Inhibitors Derived from N-Phenyl Benzotriazoles”, ACS Symposium Series, 686 (Synthesis and Chemistry of Argochemicals V), 48-54 CODEN: ACSMC8; ISSN: 0097-6156, 1998, XP009044229.
Ebisawa, M. et al, “Thiazolidinediones With Thyroid Hormone Receptor Agonistic Activity”, Chemical and Pharmaceutical Bulletin, Pharmaceutical Society of Japan. Tokyo, JP, vol. 47, No. 9, 1999, pp. 1348-1350, XP000906992; ISSN: 0009-2363.
Hutter, Michael C. et al, “QSAR of human steriod 5. alpha-reductase inhibitors: Where are the differences between isoenzyme type 1 and 2?”, Chemical Abstracts Services, XP002318310 retrieved from STN, 2004.
Winneroski, Jr. Leonard Larry
Xu Yanping
York Jeremy Schulenburg
Davis Zinna N
Eli Lilly and Company
Vorndran-Jones MaCharri
LandOfFree
Phenoxyether derivatives as PPAR modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phenoxyether derivatives as PPAR modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenoxyether derivatives as PPAR modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4076906